CDH1 and breast carcinoma: The consistent research results show that another non-canonical Hh inhibitor GANT61 (Gli1 inhibitor) can effectively increase the expression of E-cadherin in breast cancer cells and down-regulate CSC/EMT-like phenotype, thereby promoting cells apoptosis (207–209).